David A. Metcalfe - 27 Dec 2022 Form 4 Insider Report for NEXTGEN HEALTHCARE, INC.

Role: Chief Technology Officer
Signature: /s/ Jeffrey D. Linton, Attorney-in-Fact for David A. Metcalfe
Issuer symbol: N/A
Transactions as of: 27 Dec 2022
Net transactions value: -$477,294
Form type: 4
Filing time: 28 Dec 2022, 15:14:53 UTC
Previous filing: 02 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NXGN	Common Stock	Options Exercise		+42,215	+26%		203,394	27 Dec 2022	Direct	F1
transaction	NXGN	Common Stock	Tax liability	$396,624	-20,930	-10%	$18.95	182,464	27 Dec 2022	Direct	F2
transaction	NXGN	Common Stock	Tax liability	$80,670	-4,257	-2.3%	$18.95	178,207	27 Dec 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NXGN	Performance Stock Units	Options Exercise	$0	-42,215	-100%	$0.000000^*	0	27 Dec 2022	Common Stock	42,215		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Performance stock units convert to shares of NXGN common stock on a one-for-one basis once fully vested.
F2	Represents shares withheld to satisfy tax withholding obligations on the vesting of performance stock units.
F3	Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock.
F4	On December 27, 2022, 42,215 performance stock units vested for the reporting person based on the Company's achievement of fiscal year 2021 and 2022 revenue goals and modified for 3-year total shareholder return ("TSR") performance for the period December 26, 2019 through December 27, 2022.